PsychoGenics, AstraZeneca to Identify New Treatments for Central Nervous System Disorders

PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System disorders.
Earth Times